Literature DB >> 1516069

Unifocal origin of advanced human epithelial ovarian cancers.

C H Mok1, S W Tsao, R C Knapp, P M Fishbaugh, C C Lau.   

Abstract

Ovarian cancers are often diagnosed at a late stage, after the cancer cells have spread to extraovarian sites. Failure to diagnose these tumors earlier may reflect the lack of symptoms and the need for a sensitive, reliable screening test. Alternatively, this can be explained by the hypothesis that some of the extraovarian tumor implants do not represent metastatic spread from the primary cancer but instead are multiple primary tumors developing simultaneously in the peritoneal epithelium. If this is the case, some patients with advanced ovarian cancer may never have had a stage I disease, making early detection theoretically impossible. In this study, we examined the mutational pattern of the p53 gene in 9 patients with epithelial ovarian cancers using tissue collected from different sites within the same patient. In all 9 cases, the mutational pattern of the p53 gene was identical in cancer cells from different sites within the same patient, strongly suggesting that these ovarian tumors were of unifocal origin and that cancer tissues collected from different sites are derived from a single origin.

Entities:  

Mesh:

Year:  1992        PMID: 1516069

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Early detection of ovarian cancer.

Authors:  Partha M Das; Robert C Bast
Journal:  Biomark Med       Date:  2008-06       Impact factor: 2.851

3.  Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.

Authors:  Teodora A Todorova; Stanislav H Jordanov; Gergana S Stancheva; Ivan J Chalakov; Mincho B Melnicharov; Kuncho V Kunev; Vanio I Mitev; Radka P Kaneva; Teodora E Goranova
Journal:  Pathol Oncol Res       Date:  2014-08-23       Impact factor: 3.201

Review 4.  Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare.

Authors:  Robert C Bast
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

5.  A novel protease homolog differentially expressed in breast and ovarian cancer.

Authors:  A Anisowicz; G Sotiropoulou; G Stenman; S C Mok; R Sager
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

6.  Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.

Authors:  W Y Chan; K K Cheung; J O Schorge; L W Huang; W R Welch; D A Bell; R S Berkowitz; S C Mok
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis.

Authors:  Tomoki Yamano; Eiichi Morii; Isao Arai; Toshiaki Takada; Ken Kubota; Masahiko Sato; Takaaki Inoue; Yoshihiro Okada; Takahiko Hara; Katsuyuki Aozasa
Journal:  Int J Clin Oncol       Date:  2010-06-01       Impact factor: 3.402

8.  Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.

Authors:  HanByoul Cho; Eun Suk Kang; Soon Won Hong; Youn Jin Oh; Sun Mi Choi; Sang Wun Kim; Sung Hoon Kim; Young Tae Kim; Kyoung Sun Lee; Yang Kyu Choi; Jae-Hoon Kim
Journal:  Mol Cell Biochem       Date:  2008-08-06       Impact factor: 3.396

9.  Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.

Authors:  Douglas C Marchion; Yin Xiong; Hye Sook Chon; Entidhar Al Sawah; Nadim Bou Zgheib; Ingrid J Ramirez; Forough Abbasi; Xiaomang B Stickles; Patricia L Judson; Ardeshir Hakam; Jesus Gonzalez-Bosquet; Robert M Wenham; Sachin M Apte; Anders E Berglund; Johnathan M Lancaster
Journal:  Am J Obstet Gynecol       Date:  2013-08-09       Impact factor: 8.661

10.  Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.

Authors:  I B Runnebaum; X W Tong; V Moebus; V Heilmann; D G Kieback; R Kreienberg
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.